Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled study
| Autor: | KJ Tveter, Lehtonen T, J.T. Andersen, Kontturi M, Peter Ekman, Beisland Ho, Jan-Erik Johansson, Wolf H |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
medicine.medical_specialty
Chemotherapy Adenoma business.industry Urology medicine.medical_treatment Placebo-controlled study Hyperplasia urologic and male genital diseases medicine.disease law.invention Clinical trial chemistry.chemical_compound medicine.anatomical_structure Randomized controlled trial chemistry law Prostate Finasteride medicine business |
| Zdroj: | Urology. 46:631-637 |
| ISSN: | 0090-4295 |
| DOI: | 10.1016/s0090-4295(99)80291-x |
| Popis: | Objectives To study if placebo-induced improvement in men with symptomatic benign prostatic hyperplasia (BPH) is maintained over 2 years, and to study the efficacy and safety from intervention with finasteride 5 mg for 24 months. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect